When it comes to treating cancer, every pet is unique. That’s why ImpriMed offers a cutting-edge service that helps veterinarians choose the most effective cancer treatment for your dog—based on your dog’s individual cancer profile.
ImpriMed’s Personalized Prediction Profile uses advanced testing and artificial intelligence (AI) to predict how your pet’s cancer is likely to respond to different chemotherapy drugs. It’s specifically designed for canine blood cancers, such as lymphoma and leukemia.
How It Works
- Sample Collection
- Your veterinarian collects a small sample of the tumor (from a lymph node) and a blood sample.
- These are shipped overnight to ImpriMed’s lab for analysis.
- Drug Testing on Your Dog’s Cancer Cells
- ImpriMed tests a wide range of anticancer drugs directly on your dog’s live cancer cells.
- Using data from your pet’s medical history and breed, AI then predicts which treatments are most likely to work.
- Fast Results
- Within about a week, your vet receives a detailed report showing which drugs are expected to be most effective.
- This allows your care team to act quickly and choose the best treatment plan—because in cancer care, time matters.
What’s Included in the Report
CHOP Protocol Predictions
CHOP is the most commonly used first-line chemotherapy protocol for dogs with multicentric lymphoma. ImpriMed predicts:
-
- How likely your dog is to enter complete remission
- The risk of rapid disease progression after remission
Single Drug Response Predictions
ImpriMed provides individual predictions for 13 different chemotherapy drugs commonly used to treat lymphoma and leukemia—helping your vet identify the best single-agent options if CHOP isn’t the right fit.
Flow Cytometry
This advanced testing uses a panel of 10 cancer-specific antibodies to help confirm the type of cancer and predict how aggressive it may be.
PARR Test (PCR for Antigen Receptor Rearrangement)
This test helps distinguish between a cancerous lymph node and one that is simply swollen due to infection or inflammation. It provides detailed information about the specific types of immune cells (B-cells and T-cells) involved.
Sample Collection Requirements
- For Lymphoma:
- Fine needle aspirate from an enlarged lymph node
- 2 mL of blood in a purple-top (EDTA) tube
- For Leukemia:
- 2 mL of blood in a purple-top (EDTA) tube
Why Choose ImpriMed?
- Personalized care tailored to your dog’s cancer
- Faster, more informed treatment decisions
- Advanced AI technology built on real-world clinical outcomes
- May improve treatment success rates and quality of life
Talk to your veterinarian to see if ImpriMed testing is right for your pet. It’s one more way we’re bringing the power of precision medicine to veterinary care—because your dog deserves the best chance at recovery.
